A randomized phase II study of paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus and ixabepilone/carboplatin/bevacizumab as initial therapy for measurable stage III or IVA, stage IVB or recurrent endometrial cancer, GOG-86P Meeting Abstract

  

Authors:	Aghajanian, C.; Filiaci, V. L.; Dizon, D. S.; Carlson, J.; Powell, M. A.; Secord, A. A.; Tewari, K. S.; Bender, D.; O'Malley, D. M.; Stuckey, A.; Rotmensch, J.; Levine, D. A.; Lankes, H. A.; Moore, K. N.
Abstract Title:	A randomized phase II study of paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus and ixabepilone/carboplatin/bevacizumab as initial therapy for measurable stage III or IVA, stage IVB or recurrent endometrial cancer, GOG-86P
Meeting Title:	51st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	33
Issue:	15 Suppl.
Meeting Dates:	2015 May 29-Jun 2
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2015-05-20
Language:	English
ACCESSION:	WOS:000358036901158
PROVIDER:	wos
DOI:	10.1200/jco.2015.33.15_suppl.5500
Notes:	Meeting Abstract: 5500 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/80345